Active glucocorticoid — prednisone is reduced to prednisolone by hepatic 11β-HSD1. Direct prednisolone use bypasses the activation step (preferred in liver dysfunction). ~4× cortisol potency. Same indications + adverse effect profile as prednisone.
Half-Life & Elimination Curve (PO: 3h · IV: 3h)
Plasma (PO)t½ Decay (3h)Effect Site (ke0)
0×t½0h100%(0.242 mg/L)
1×t½3h50%(0.121 mg/L)
2×t½6h25%(60.5 µg/L)
3×t½9h12.5%(30.2 µg/L)
4×t½12h6.3%(15.1 µg/L)
5×t½15h3.1%(7.56 µg/L)
Elimination t½3h (PO)
Rate Constant (ke)0.231 h⁻¹
Time to Peak (Tmax)1.47h
Est. Peak (Cmax)0.242 mg/L
Clearance (CL)11.6 L/h
97% Washout (5×t½)15h
Dosing Guidelines
Oral (PO): Typical 20 mg (Range: 5–60 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 85% · Volume of Distribution (Vd): 50 L · Absorption (ka): 1.5 h⁻¹ (t½ka ≈ 28m) [PMID 2285202]
Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 50 L [PMID 2285202]